ISRCTN72921325Completed未知
A post-market, long-term, prospective, observational, multi-site outcome study to assess the clinical course and seizure reduction of patients treated with adjunctive vagus nerve stimulation therapy in France
ivaNova Belgium N.V.0 sites150 target enrollmentStarted: April 26, 2013Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 150
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. All newly patients implanted with a VNS device
- •2. Patients must have received the information letter and agreed that their data will be collected and transmitted to Cyberonics for analysis
Exclusion Criteria
- •Does not meet inclusion criteria
- •The investigator should refer to the instructions for VNS Therapy use
Investigators
Similar Trials
Completed
Phase 4
Post Market Clinical Follow Up of Skanray s Patient MonitorsCTRI/2022/05/042811Skanray Technologies Limited
Completed
Not Applicable
Post Market Clinical Follow Up Investigation of Intraskan DCCTRI/2020/12/029746Skanray Technologies Pvt Ltd
Completed
Phase 4
Post Market Clinical Follow Up Investigation of SKAN CCTRI/2020/12/029836Skanray Technologies Pvt Ltd
Completed
Phase 4
Post Market Clinical Follow Up of SkanRespiro Plus and PranaaCTRI/2022/05/042810Skanray Technologies Limited
Completed
Phase 4
Post Market Clinical Follow Up Investigation of Skanmobile and Skanmobile DRCTRI/2020/09/028059Skanray Technologies Pvt Ltd